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Crystal-Violet Vaccille 
Experiments with crystal-violet vaccine 
for the prevention of hog cholera 
C. G. Cole, D.V.M.* 
FOR MANY years, research workers have endeavored to produce a vaccine 
from the blood of cholera infected pigs. 
Numerous chemical agents, heat, cold and 
desiccation have been used in attempts 
to destroy or attenuate the disease-produc-
ing properties of the blood and at the same 
time preserve its antigenic properties. 
Investigators have been encouraged by 
the results of certain experiments, only to 
find that similar results could not be ob-
tained in subsequent experiments carried 
out in exactly the same manner. 
The need for an immunizing agent which 
would produce immunity against hog chol-
era without the danger connected with the 
use of live virus has long been recognized. 
The use of anti-hog-cholera serum in 
conjunction with hog-cholera virus, known 
as the serum-virus method of immuniza-
tion, or vaccination, has been of inestim-
able value in the prevention of hog cholera 
and this method of immunization is now 
employed extensively throughout the 
world. However, there have always been 
certain inherent drawbacks associated 
with this valuable prophylactic method. 
The chief objection to the serum-virus 
method of immunization is the fact that a 
live and active virus is used in conjunction 
with the serum. When a live virus is in-
jected into a susceptible hog, even with 
large doses of serum, a reaction always 
follows. This reaction, in the majority of 
cases, is invisible. However, experiments 
conducted by the Bureau have shown that 
a leucopenia regularly follows the simul-
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taneous inoculation of serum and virulent 
blood, even in pigs which exhibited no 
fever and no visible symptoms. When the 
dose of serum was nearly double the 
amount required to prevent the develop-
ment of visible symptoms, the leucopenia 
was still observed. In addition, there is 
the well established fact that the simul-
taneous inoculation is always followed by 
the appearance of the virus in the blood, 
where it circulates for two or three weeks 
even though there is no rise in tempera-
ture and no visible reactions. 
In the case of perfectly normal and 
healthy swine, there is no danger from 
serum-virus immunization, but when sec-
ondary bacterial infections are present at 
the time of vaccination or are picked up 
shortly thereafter, the method may be 
fraught with danger, for the virus seems 
prone to activate such infections. Not only 
are bacterial infections, infestations with 
parasites, nutritional disturbances, and 
other delibitating conditions apt to be 
made more severe by the reaction follow-
ing serum-virus vaccination, but the ser-
um-virus reaction is itself likely to be in-
tensified by the presence of any debilitat-
ing condition. 
With a view of overcoming these objec-
tionable features connected with the 
serum-virus method of immunization, offi-
cials and research workers in the Bureau 
of Animal Industry have had in mind for 
many years the development of a vaccine 
which would afford a safer and cheaper 
method of immunization. Much time and 
a great amount of work have been devoted 
to the preparation and t~sting of experi-
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mental vaccines at the Bureau Experi-
ment Station at Ames, Iowa, during the 
last fifteen or twenty years. 
Crystal-Violet Vaccine 
Crystal-violet vaccine is a modified 
virus made from the defibrinated blood of 
cholera pigs. It derives its name from the 
fact that crystal violet, an aniline dye de-
rived from coal tar, is the principal attenu-
ating agent used in its preparation. The 
late Doctor Marion Dorset, former chief 
of the Biochemic Division of the Bureau 
of Animal Industry, was the originator of 
the idea of using this dye in the produc-
tion of hog-cholera vaccine. 
The first lot of crystal-violet vaccine was 
prepared in November 1934, at the Bureau 
Experiment Station at Ames. The dye 
was first used alone and later in combina-
tion with several other chemical agents. 
Many experiments were conducted before 
a formula was discovered which could be 
used repeatedly with satisfactory results. 
The present formula was first used in May 
1936, and since then many lots of vaccine 
have been prepared by the same method, 
which is briefly as follows: 
To 800 cc. of selected defibrinated hog-
cholera blood, 100 cc. of a three percent 
solution of disodium phosphate is slowly 
added while stirring. Next, 100 cc. of a 
0.5 percent solution of crystal violet is 
added in the same manner. The mixture 
is placed in an incubator and left there for 
two weeks at a temperature of 37.5°C. 
Bacteriological examinations' are made of 
the tissues of the pigs furnishing the virus 
and of the vaccine when it is removed 
from the incubator. After removal from 
the incubator the vaccine is kept in a 
refrigerator. 
Potency Tests 
Pigs weighing from forty to seventy 
pounds and of known susceptibility are 
used in potency tests. Two are injected 
with 3 cc., two with 5 cc. and two with 
10 cc. of the vaccine and two are left un-
treated to serve as controls. In conducting 
these tests the vaccine is injected in the 
loose tissue of the thigh, beneath the sub-
cutaneous tissue and fascia, but not in the 
muscular tissue. The test pigs are placed 
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in clean, disinfected, outside pens, and 
kept under careful observation and away 
from exposure for three weeks. Previous 
tests have established the fact that an 
interval of from two to three weeks is re-
quired to establish immunity. Each pig 
is then given an injection of 1 cc. of virus 
of known virulence and carefully observed 
for another two weeks. Five weeks are 
thus required in carrying out the potency 
tests. 
Numerous lots of vaccines have been 
prepared by the above-described method 
and several hundred pigs have been used 
in conducting the tests. The tests have 
demonstrated that the method used in the 
preparation of the vaccine had in all cases 
attenuated the virus to a point where it 
would no longer produce hog cholera in 
from 1 cc. to 10 cc. doses and that vaccine-
treated pigs possess a high degree of im-
munity three weeks after vaccine admin-
istration. 
Farm Tests 
In carrying out these experiments, the 
nature of the new vaccine was carefully 
explained to each cooperating farmer. It 
was pointed out and emphasized that the 
treatment was in an experimental stage 
and its limitations as well as advantages 
were fully explained. The farmers were 
assured that the method was a safe one 
and that no ill effects would follow vacci-
nation of their herds. They were also told 
that because of the slow development of 
immunity the vaccine should not be used 
in a neighborhood or community where 
hog cholera was known to be prevalent. 
Herds were therefore selected for treat-
ment in communities where no cholera 
prevailed. 
In the treatment of farm herds, every 
precaution was taken to prevent the intro-
duction of disease. Equipment and cloth-
ing were used which had not come in con-
tact with hog-cholera virus. 
The herds were not kept under obser-
vation following vaccination, as this was 
not considered necessary in view of the 
absence of any symptoms of sickness in 
experimental and test pigs at the Bureau 
Station. 
The farmers were informed that the 
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vaccine appeared to protect the treated 
animals through the usual fattening pe-
riod, but no guarantee was given as to the 
duration of immunity. Retreatment with 
vaccine or serum-virus treatment at the 
end of eight months was advised for ani-
mals to be kept for breeding stock. 
The treatment was administered free of 
charge with the one proviso that when the 
pigs were ready for market a certain num-
ber of animals from each herd, usually 
four, would be delivered to the Bureau 
Station for an immunity test. These hogs 
were purchased at the prevailing market 
price or immune hogs of equivalent value 
were given in exchange. 
News of the new treatment spread rap-
idly throughout the surrounding country 
and farmers made applications for the 
treatment in large numbers. The first farm 
herd was treated on November 5, 1935, 
near the Ames Station. Since that time, 
248 herds containing 13,281 pigs have been 
treated with vaccine made by the im-
proved formula. In order to ascertain 
whether the vaccine possessed or would 
regain virulence during the animal pas-
sage, 196 untreated controls were left in 
78 of these herds, and no sickness devel-
oped in these pigs. 
Administration 
The vaccine was administered by sub-
cutaneous injection on the inner side of 
the thigh. Pigs weighing under 75 pounds 
received a 5 cc. dose while those weighing 
over 75 pounds were given a 10 cc. dose. 
In a limited number of herds, a portion of 
the herd was given two treatments admin-
istered two weeks apart. Ear marks were 
used to identify the various groups. 
Herd owners were instructed to report 
in case sickness of any kind developed. 
In only three of the 248 herds treated did 
any disease develop which required an 
investigation. Sickness developed two 
weeks after treatment in one herd and two 
months after treatment in the other two 
herds. In these herds lesions were found 
that could be regarded as suspicious of 
cholera and they were treated with serum 
and virus. However, two pigs were pur-
chased by the Bureau from two of these 
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farms and left in the herds without any 
treatment except the original vaccine 
treatment. All of these pigs remained 
normal. 
The treatment of 248 herds consisting of 
13,281 pigs with sickness developing in 
only three herds during the fattening pe-
riod, would seem to furnish evidence that 
the crystal-violet vaccine is a safe product 
to use. 
In some recent farm experiments herds 
which are sometimes referred to by prac-
ticing veterinarians as problem herds have 
been selected for treatment with crystal-
violet vaccine. These are herds which 
quite regularly show visible reactions fol-
lowing the administration of serum and 
virus. In one such herd, apparently well 
when treated, a loss of 75 percent of the 
hogs was sustained after the administra-
tion of serum and virus. No visible re-
actions occurred when crystal-violet vac-
cine was administered to these herds. 
Immunity Tests 
As previously stated, when the vaccine-
treated hogs were ready for market a 
number of hogs were selected from as 
many herds as possible for the purpose of 
testing their immunity. 
These hogs were brought to the Experi-
ment Station and injected with 2 cc. each 
of tested virus. In a few cases pen expo-
sure was substituted for virus injection. 
Removing hogs from farm herds and 
subjecting them to changes in feed, care 
and housing conditions, in addition to an 
injection of hog-cholera virus, constitute 
a severe test. Furthermore, many of these 
tests were conducted during severe win-
ter weather. Had it beeen possible to ex-
pose these hogs on farms under their 
normal surroundings it is probable that 
the results would have been somewhat 
better. Any symptom of sickness follow-
ing exposure was recorded as a reaction 
regardles of the cause or nature of the 
sickness. 
The interval between vaccine treatment 
and exposure varied from two to twelve 
months, the majority of the hogs being 
exposed at from five to eight months. 
(Continued on page 158) 
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In all, 841 hogs from 222 farm herds 
treated with vaccine prepared by the 
above-described method have been sub-
jected to immunity tests. A number of 
these hogs were treated by procedures 
which would not be considered good prac-
tice in the light of present knowledge. Ap-
proximately 83 percent either remained 
normal or showed only a slight reaction, 
12 percent showed severe reactions and 5 
percent died. 
Included in the foregoing tests were 
market hogs that had been treated with 
vaccine before weaning. As will be dis-
cussed later in detail, it was found that 
unweaned pigs, particularly those farrow-
ed by immune mothers, were not well pro-
tected by the vaccine. Confining the sum-
mary to pigs vaccinated when 10 weeks 
of age or over and tested by virus injec-
tion within the following 8 months, 89 
percent were found adequately protected 
and only 1 percent died. 
The fact that the hogs in the group 
which exhibited severe reactions recover-
ed and a number of those in the group 
which succumbed died from causes other 
than hog cholera would indicate that con-
siderably more than 83 percent of all farm 
hogs that were subjected to immunity 
tests had received some protection from 
the vaccine treatment. 
Duration of Immunity 
While the duration of immunity follow-
ing treatment with crystal-violet vaccine 
has not, as yet, been definitely established, 
the vaccine seems to protect swine against 
cholera quite well through the fattening 
period, provided they have not been 
treated when under eight or ten weeks of 
age. 
Vaccine Treatment of Pigs Nursing 
Non-Immune and Immune Sows 
The observation was made in the course 
of earlier experiments with crystal-violet 
vaccine that there was a distinct inter-
ference in the antigenic action of the vac-
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cine when anti-hog-cholera serum is given 
at the same time as or shortly after the 
vaccine. The passive immunity from the 
serum evidently interfered with the usual 
antigenic action of the vaccine. 
With a view to determining whether a 
similar interference might occur when the 
vaccine was given to pigs nursing immune 
sows, an experiment was carried out at 
the Bureau Station in which a group of 
little pigs nursing non-immune sows and 
another group nursing immune sows were 
treated with crystal-violet vaccine and 
later exposed by virus injection with a 
very striking difference in results. The 
protection afforded the first group was 
100 percent and in the second group only 
61.5 percent. This would indicate that the 
natal immunity in pigs nursing immune 
sows interferes with the antigenic action 
of the vaccine in a similar manner that 
was noted in the experiments where anti-
hog-cholera serum was given in conjunc-
tion with the vaccine or shortly there-
after. 
Tests in Cooperation with 
Practicing Veterinarians 
In the spring of 1940 arrangements were 
made for the distribution of the vaccine 
through Government channels to veteri-
narians in various parts of the country in 
order that the new product could be tried 
out in the hands of practitioners and re-
sults compared with those obtained in 
farm tests around Ames. Vaccine has been 
distributed to veterinarians in Iowa and 
a number of other states. This project is 
being continued as well as other experi-
mental work with various phases of cry-
stal-violet vaccine. 
PALOMINO 
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separate room with running water, electric 
lights, and with a thick layer of straw on 
the floor. Every morning, each stallion is 
walked, trotted, and galloped for ten 
miles, and when lathery is allowed to roll 
in fine beach sand which helps maintain 
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